PALM2-AKAP2 inhibitors are a distinctive class of chemical compounds designed to target and modulate the function of the PALM2-AKAP2 protein complex. The PALM2-AKAP2 complex is involved in the spatial and temporal regulation of signaling pathways within the cell, particularly those related to cyclic AMP (cAMP) signaling and protein kinase A (PKA) activity. PALM2, a member of the parvin family of proteins, is known for its role in organizing actin filaments and linking them to various signaling proteins. AKAP2 (A-kinase anchoring protein 2) is crucial for anchoring PKA to specific subcellular locations, thereby ensuring precise regulation of cAMP-dependent signaling pathways.
Inhibitors of the PALM2-AKAP2 complex function by disrupting the interaction between PALM2 and AKAP2, or by otherwise modifying the structural and functional dynamics of this protein complex. This disruption can affect the localization and activity of PKA, leading to altered signaling outcomes within the cell. By targeting the PALM2-AKAP2 interaction, these inhibitors provide insights into the mechanisms by which spatially restricted signaling pathways influence cellular processes. The study of PALM2-AKAP2 inhibitors contributes to a broader understanding of how cells regulate complex signaling networks, including those involved in cellular growth, differentiation, and motility. These inhibitors are valuable tools for dissecting the specific functions of the PALM2-AKAP2 complex and elucidating its role in various cellular contexts.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
H-89 dihydrochloride | 130964-39-5 | sc-3537 sc-3537A | 1 mg 10 mg | $94.00 $186.00 | 71 | |
Inhibits Protein Kinase A (PKA), which may disrupt the PKA anchoring function of AKAPs, thereby affecting PALM2-AKAP2's role in targeting PKA to specific locations. | ||||||
Rp-cAMPS | 151837-09-1 | sc-24010 | 1 mg | $203.00 | 37 | |
PKA inhibitor that competes with cAMP, potentially disrupting the PALM2-AKAP2 associated PKA signaling pathways. | ||||||
PKI (14-22) amide (myristoylated) | 201422-03-9 | sc-471154 | 0.5 mg | $135.00 | 2 | |
Selective PKA inhibitor peptide that can interfere with PKA activity linked to AKAPs, possibly impacting PALM2-AKAP2 functions. | ||||||
KT 5720 | 108068-98-0 | sc-3538 sc-3538A sc-3538B | 50 µg 100 µg 500 µg | $138.00 $220.00 $972.00 | 47 | |
PKA inhibitor that can prevent the activation of PKA by PALM2-AKAP2, thereby affecting downstream signaling. | ||||||
ML-7 hydrochloride | 110448-33-4 | sc-200557 sc-200557A | 10 mg 50 mg | $91.00 $267.00 | 13 | |
Inhibits myosin light-chain kinase, which can impact cytoskeletal dynamics and indirectly influence PALM2-AKAP2-mediated signaling processes. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
PI3K inhibitor that can alter AKAP-dependent signaling by affecting PI3K-Akt pathways, where PALM2-AKAP2 might be involved. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
MEK inhibitor that can alter the ERK/MAPK pathway, potentially influencing PALM2-AKAP2's role in signaling cascades. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
p38 MAPK inhibitor that can modify the MAPK pathway, potentially affecting the signaling functions of PALM2-AKAP2. | ||||||
KN-93 | 139298-40-1 | sc-202199 | 1 mg | $182.00 | 25 | |
Inhibits Ca2+/calmodulin-dependent protein kinase II, which may interact with AKAP complexes and thus could impact PALM2-AKAP2. | ||||||
Gö 6983 | 133053-19-7 | sc-203432 sc-203432A sc-203432B | 1 mg 5 mg 10 mg | $105.00 $299.00 $474.00 | 15 | |
Protein kinase C inhibitor that may alter the AKAP-mediated signaling and affect the function of PALM2-AKAP2. | ||||||